Ex vivo expanation T CD4+ and T CD8+ isolated from human peripheral blood mononuclear cells

Immunotherapy is currently an attractive method in the treatment of cancer. Immune cells are isolated, activated, ex vivo proliferated, functionally manipulation and then given back into the patient. In this study, CD4+ and CD8+ T cells from human Peripheral Blood Mononuclear Cells (PBMCs) were isol...

Full description

Saved in:
Bibliographic Details
Published in:Tạp chí Khoa học Đại học Mở Thành phố Hồ Chí Minh - Kỹ thuật và Công nghệ (Bản điện tử) Vol. 17; no. 2; pp. 59 - 67
Main Authors: Phùng Thị Việt Anh, Võ Nguyễn Thanh Thảo, Nguyễn Đăng Quân
Format: Journal Article
Language:English
Published: HO CHI MINH CITY OPEN UNIVERSITY JOURNAL OF SCIENCE 01-09-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunotherapy is currently an attractive method in the treatment of cancer. Immune cells are isolated, activated, ex vivo proliferated, functionally manipulation and then given back into the patient. In this study, CD4+ and CD8+ T cells from human Peripheral Blood Mononuclear Cells (PBMCs) were isolated, ex vivo activated and cultured under the conditions of using coated magnetic beads CD3/CD28 at the ratio of 01 bead: 01 cell supplemented with 30 U/mL IL-2 in the culture medium. The number of cells was counted every day by staining with Trypan Blue.The percentage of CD3+CD4+ and CD3+CD8+ cell populations was confirmed by flow cytometry. After 10 days, the CD4+ T cell could proliferate strongly, the total cell number is approximately 6.5 x 107 cells, increasing more than 30 times compared with the cell number on the first day. For CD8+ T cells, there was also a slight increase in cell number, reaching to 3 x 106 cells. Flow cytometry results showed that the CD4+ T cell population still maintained a CD3+/CD4+ population more than 90% at day 04. In contrast, the CD3+/CD8+ ratio in CD8+ population was only 40% even though the total cell number increased in this population. Taken together, these data indicated that we were able to isolate and culture ex vivo CD4+ and CD8+ T cells.
ISSN:2734-9322
2734-9594
DOI:10.46223/HCMCOUJS.tech.vi.17.2.2133.2022